OA12008A - Bioavailable dosage form of isotretinoin. - Google Patents

Bioavailable dosage form of isotretinoin. Download PDF

Info

Publication number
OA12008A
OA12008A OA1200200055A OA1200200055A OA12008A OA 12008 A OA12008 A OA 12008A OA 1200200055 A OA1200200055 A OA 1200200055A OA 1200200055 A OA1200200055 A OA 1200200055A OA 12008 A OA12008 A OA 12008A
Authority
OA
OAPI
Prior art keywords
formulation
oil
drug
acid
claiming
Prior art date
Application number
OA1200200055A
Other languages
English (en)
French (fr)
Inventor
Inderdeep Bhatia
Rajiv Malik
Abha Pant
Sunilendu Bhushan Roy
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Publication of OA12008A publication Critical patent/OA12008A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
OA1200200055A 2000-06-16 2001-04-09 Bioavailable dosage form of isotretinoin. OA12008A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN596DE2000 IN192188B (cs) 2000-06-16 2000-06-16

Publications (1)

Publication Number Publication Date
OA12008A true OA12008A (en) 2006-04-19

Family

ID=11097063

Family Applications (1)

Application Number Title Priority Date Filing Date
OA1200200055A OA12008A (en) 2000-06-16 2001-04-09 Bioavailable dosage form of isotretinoin.

Country Status (25)

Country Link
US (1) US6740337B2 (cs)
EP (1) EP1294357A1 (cs)
JP (1) JP2004503493A (cs)
CN (1) CN1196475C (cs)
AP (1) AP2002002423A0 (cs)
AU (1) AU782094B2 (cs)
BG (1) BG106414A (cs)
BR (1) BR0106752A (cs)
CA (1) CA2382065A1 (cs)
CZ (1) CZ2002694A3 (cs)
EA (1) EA004808B1 (cs)
EE (1) EE200200074A (cs)
HK (1) HK1052302A1 (cs)
HR (1) HRP20020148A2 (cs)
HU (1) HUP0203717A3 (cs)
IL (1) IL148176A0 (cs)
IN (1) IN192188B (cs)
MX (1) MXPA02001669A (cs)
NZ (1) NZ517142A (cs)
OA (1) OA12008A (cs)
PL (1) PL352838A1 (cs)
SK (1) SK2252002A3 (cs)
UA (1) UA74793C2 (cs)
WO (1) WO2001095886A1 (cs)
ZA (1) ZA200201240B (cs)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60104206T2 (de) * 2000-09-22 2005-09-22 Galephar M/F Halbfeste arzneizubereitung enthaltend isotretinoin
EP1527774A1 (en) 2003-11-03 2005-05-04 Basilea Pharmaceutica AG New formulation for retinoid-containing soft gelatin capsules
WO2004103346A1 (en) * 2003-05-20 2004-12-02 Ranbaxy Laboratories Limited Pharmaceutical compositions of acitretin
US20070254025A1 (en) * 2006-04-27 2007-11-01 Cronk Peter J Oral contraceptive and acne medication combination and treatment of acne with reduced side effects
US20070254858A1 (en) * 2006-04-27 2007-11-01 Cronk Peter J Contraceptive and Acne Medication Combination and Treatment of Acne and Other Diseases with Reduced Side Effects
AU2008215659B2 (en) 2007-02-16 2012-11-01 Aska Pharmaceutical Co., Ltd. Pharmaceutical composition comprising microparticle oily suspension
WO2008102375A2 (en) * 2007-02-20 2008-08-28 Ipca Laboratories Limited A process for preparation of highly pure isotretinoin
US9078925B2 (en) 2012-06-18 2015-07-14 Galephar Pharmaceutical Research, Inc. Pharmaceutical semi-solid composition of isotretinoin
JP2018520114A (ja) * 2015-05-25 2018-07-26 サン ファーマシューティカル インダストリーズ リミテッドＳｕｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｉｎｄｕｓｔｒｉｅｓ Ｌｔｄ． イソトレチノインの１日１回経口医薬組成物
US10517846B2 (en) 2016-05-26 2019-12-31 Dr. Reddy's Laboratories Ltd. Pharmaceutical compositions for treating acne

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4016254A (en) * 1972-05-19 1977-04-05 Beecham Group Limited Pharmaceutical formulations
CA1282326C (en) * 1984-12-14 1991-04-02 Paul J. Jarosz Pharmaceutical composition containing 13-cis vitamin a acid as the active ingredient
US4808630A (en) 1987-01-16 1989-02-28 United States Of America Method of treating psychotic illnesses
US6045829A (en) * 1997-02-13 2000-04-04 Elan Pharma International Limited Nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors using cellulosic surface stabilizers
PE20001227A1 (es) 1998-10-30 2000-11-06 Hoffmann La Roche Procesos para producir una composicion de isotretinoina
US6284283B1 (en) * 1999-10-21 2001-09-04 Alkermes Controlled Therapeutics, Inc. Method of producing sub-micron particles of biologically active agents and uses thereof

Also Published As

Publication number Publication date
IL148176A0 (en) 2002-09-12
AU4445901A (en) 2001-12-24
MXPA02001669A (es) 2002-08-06
HRP20020148A2 (en) 2003-12-31
CN1388757A (zh) 2003-01-01
PL352838A1 (en) 2003-09-08
HUP0203717A2 (hu) 2003-04-28
WO2001095886A1 (en) 2001-12-20
EP1294357A1 (en) 2003-03-26
BG106414A (en) 2002-09-30
EA004808B1 (ru) 2004-08-26
CZ2002694A3 (cs) 2002-08-14
BR0106752A (pt) 2002-04-16
SK2252002A3 (en) 2002-08-06
AP2002002423A0 (en) 2002-03-31
US6740337B2 (en) 2004-05-25
HK1052302A1 (zh) 2003-09-11
HUP0203717A3 (en) 2003-05-28
NZ517142A (en) 2003-08-29
IN192188B (cs) 2004-03-13
AU782094B2 (en) 2005-06-30
JP2004503493A (ja) 2004-02-05
US20020025338A1 (en) 2002-02-28
ZA200201240B (en) 2002-09-02
UA74793C2 (en) 2006-02-15
EE200200074A (et) 2003-04-15
CN1196475C (zh) 2005-04-13
CA2382065A1 (en) 2001-12-20
EA200200166A1 (ru) 2002-10-31

Similar Documents

Publication Publication Date Title
US7314643B2 (en) Soft capsule preparation
EP0184942B1 (en) Improved pharmaceutical composition containing 13-cis vitamin a acid as the active ingredient
JP3903061B2 (ja) 薬物を含有するナノ粒子およびその製造方法、ならびに当該ナノ粒子からなる非経口投与用製剤
EP1207872A1 (en) Ibuprofen-containing softgels
OA12008A (en) Bioavailable dosage form of isotretinoin.
JPH0640928A (ja) アントシアノシド類を含有する経口医薬組成物
JP5750278B2 (ja) カンデサルタンシレキセチルのカプセル充填用組成物
EP1455730A1 (en) Isotretinoin nanoparticulate compositions
JP5441337B2 (ja) 薬物の吸収性が改善された医薬組成物
DK169566B1 (da) Flydende farmaceutisk præparat indeholdende en 4-aroyl-imidazol-2-on til anvendelse i doseringsformer til oral indgivelse samt fremgangsmåde til fremstilling af præparatet
US20240122851A1 (en) Vitamin d formulations
KR101234253B1 (ko) 안정성이 향상된 경구용 엽산 연질캡슐제
JPS6277320A (ja) Ｌ−アスコルビン酸製剤およびその製造法
JP2885668B2 (ja) テプレノン製剤
CN118304270A (zh) 一种维生素d滴剂及其制备方法
WO2002060437A1 (en) Pharmaceutical compositions including sampatrilat dispersed in a lipoidic vehicle
AU2002240206A1 (en) Pharmaceutical compositions including sampatrilat dispersed in a lipoidic vehicle
KR101012903B1 (ko) 나노입자 형성을 이용하는 리세드로네이트 경질캡슐
WO2014010008A1 (ja) カンデサルタンシレキセチルのカプセル充填用組成物